(Q39365679)

11 September 2017

title

9-year HIV-2-associated mortality in an urban community in Bissau, west Africa (English)

1 reference

11 September 2017

0 references

0 references

P Aaby

2

0 references

Mads Melbye

9

object named as

M Melbye

1 reference

11 September 2017

A G Poulsen

1

1 reference

11 September 2017

O Larsen

3

1 reference

11 September 2017

H Jensen

4

1 reference

11 September 2017

A Nauclér

5

1 reference

11 September 2017

I M Lisse

6

1 reference

11 September 2017

C B Christiansen

7

1 reference

11 September 2017

F Dias

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

11 September 2017

1 reference

11 September 2017

volume

349

1 reference

11 September 2017

issue

9056

1 reference

11 September 2017

page(s)

911-914

1 reference

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Antibodies to HTLV-IV associated with chronic, fatal illness resembling "slim" disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

The effects of HIV-2 infection in a rural area of Guinea-Bissau.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Slower heterosexual spread of HIV-2 than HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

HIV-2-infected patients survive longer than HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Two-year HIV-1-associated mortality in a Ugandan rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

Progesterone implants enhance SIV vaginal transmission and early virus load

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2904402-9

7 January 2021

10.1016/S0140-6736(96)04402-9

Identifiers

DOI

1 reference

11 September 2017

1 reference